Forte Biosciences (FBRX) Other Working Capital Changes (2016 - 2026)

Forte Biosciences (FBRX) has 3 years of Other Working Capital Changes data on file, last reported at $328000.0 in Q1 2020.

• On a quarterly basis, Other Working Capital Changes rose 3744.44% year-over-year to $328000.0 in Q1 2020; TTM through Mar 2020 was $301000.0, a 60.76% decrease from a year earlier, with the FY2019 full-year figure at -$36000.0, down 103.85% from the prior year.
• Other Working Capital Changes for Q1 2020 stood at $328000.0, up from -$316000.0 in the prior quarter.
• Over the last five years, Other Working Capital Changes for FBRX reached as high as $3.2 million in Q1 2026 and fell as low as -$1.6 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged $455000.0 across 5 years, with a median of $17000.0 in 2024.
• Across the five-year window, Other Working Capital Changes plunged 281.61% in 2019 and jumped 3744.44% in 2020, its largest moves.
• Year by year, Other Working Capital Changes stood at $174000.0 in 2018, then plunged by 281.61% to -$316000.0 in 2019, then surged by 203.8% to $328000.0 in 2020.
• Per Business Quant data, the three most recent Other Working Capital Changes figures were $328000.0 in Q1 2020, -$316000.0 in Q4 2019, and $298000.0 in Q3 2019.